Geode Capital Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.1K | Sell |
|
|||||
|
2025
Q1 | $73.3K | Buy |
|
|||||
|
2024
Q4 | $119K | Buy |
|
|||||
|
2024
Q3 | $152K | Buy |
|
|||||
|
2024
Q2 | $164K | Buy |
|
|||||
|
2024
Q1 | $202K | Hold |
|
|||||
|
2023
Q4 | $97.5K | Buy |
|
|||||
|
2023
Q3 | $62.2K | Buy |
|
|||||
|
2023
Q2 | $568K | Hold |
|
|||||
|
2023
Q1 | $910K | Buy |
|
|||||
|
2022
Q4 | $448K | Sell |
|
|||||
|
2022
Q3 | $1.22M | Buy |
|
|||||
|
2022
Q2 | $761K | Sell |
|
|||||
|
2022
Q1 | $952K | Buy |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $909K | Buy |
|
|||||
|
2021
Q2 | $1.01M | Sell |
|
|||||
|
2021
Q1 | $1.83M | Buy |
|
|||||
|
2020
Q4 | $1.84M | Buy |
|
|||||
|
2020
Q3 | $6.77M | Buy |
|
|||||
|
2020
Q2 | $4.41M | Buy |
|
|||||
|
2020
Q1 | $786K | Buy |
|
|||||
|
2019
Q4 | $613K | Hold |
|
|||||
|
2019
Q3 | $558K | Buy |
|
|||||
|
2019
Q2 | $521K | Buy |
|
|||||
|
2019
Q1 | $456K | Hold |
|
|||||
|
2018
Q4 | $373K | Hold |
|
|||||
|
2018
Q3 | $402K | Hold |
|
|||||
|
2018
Q2 | $410K | Buy |
|
|||||
|
2018
Q1 | $269K | Hold |
|
|||||
|
2017
Q4 | $335K | Hold |
|
|||||
|
2017
Q3 | $353K | Hold |
|
|||||
|
2017
Q2 | $356K | Buy |
|
|||||
|
2017
Q1 | $311K | Buy |
|
|||||
|
2016
Q4 | $155K | Hold |
|
|||||
|
2016
Q3 | $146K | Hold |
|
|||||
|
2016
Q2 | $147K | Hold |
|
|||||
|
2016
Q1 | $163 | Hold |
|
|||||
|
2015
Q4 | $175K | Hold |
|
|||||
|
2015
Q3 | $140K | Hold |
|
|||||
|
2015
Q2 | $221K | Hold |
|
|||||
|
2015
Q1 | $272K | Buy |
|
|||||
|
2014
Q4 | $82K | Buy |
|